ADAMTS13 Expression in Defined Media via Calcium Zinc Nicotinamide
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing ADAMTS proteins face challenges in achieving high specific activities and are contaminated with animal-derived components, leading to variability and safety concerns in pharmaceutical applications.
Innovation Solution
Supplementing culture media with increased levels of calcium, zinc, and nicotinamide to enhance ADAMTS protein expression and activity, using animal protein-free and chemically defined mediums to minimize contamination, and stabilizing the proteins during purification with additional calcium and zinc in buffers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If animal-derived serum or protein additives are used in cell culture media, then cell growth and protein expression are enhanced, but contamination with viruses, BSE, and other pathogens occurs
Solution Approach 1:
The invention extracts and removes animal-derived serum and protein additives from cell culture media, replacing them with chemically defined components. This elimination of animal products removes the source of viral, BSE, and other pathogen contamination while maintaining cell culture productivity through optimized synthetic media formulations.
Solution Approach 2:
The invention changes the chemical composition parameters of cell culture media by transitioning from undefined animal-derived products to precisely defined synthetic components. This parameter change includes specifying exact concentrations of amino acids, vitamins, minerals, and growth factors, thereby eliminating contamination risks while optimizing protein expression through controlled nutritional parameters.
2Ease of manufacture
If conventional cell culture media are used, then production cost is reduced, but batch-to-batch variability in protein quality occurs
Solution Approach 1:
The invention transforms cell culture media from undefined compositions to precisely defined chemical formulations with specified concentrations of all components. This parameter standardization eliminates batch-to-batch variability in protein quality while maintaining cost-effectiveness through optimized synthetic media that do not require expensive quality testing of animal-derived products.
Solution Approach 2:
The invention replaces expensive, variable animal-derived serum that requires extensive quality testing and validation with affordable, consistent synthetic media components. These chemically defined media can be manufactured at scale with precise control, eliminating the need for batch-by-batch characterization and reducing overall production costs while ensuring protein quality consistency.
3Quantity of substance
If ADAMTS proteins are produced using traditional methods, then production volume is achieved, but specific activity and purity are insufficient for pharmaceutical use
Solution Approach 1:
The invention optimizes cell culture conditions by precisely controlling media composition parameters including amino acid profiles, vitamin concentrations, mineral content, and growth factor levels. These parameter optimizations enhance ADAMTS protein specific activity and purity during production, enabling pharmaceutical-grade protein recovery at scalable volumes through improved cellular metabolism and protein folding in defined media environments.
Data Source
AI summary
The present invention provides culture mediums that are useful for the expression of ADAMTS proteins, such as ADAMTS13. Methods for the expression and purification of ADAMTS proteins are also provided. In some embodiments, the mediums and methods of the invention are useful for the expression of ADAMTS proteins having high specific activities. Also provided are ADAMTS, e.g., ADAMTS13, protein compositions with high specific activities, which are expressed and purified according to the methods provided herein.